Jill E. Stopfer

4.4k citations

69 papers · 2.6k indexed · 1 hit paper · h-index 31

Impact in

Genetics top 0.5%
- BRCA gene mutations in cancer
- Genomic variations and chromosomal abnormalities
- Genomics and Rare Diseases
Cancer Research top 5%
- Cancer Genomics and Diagnostics

Papers in ⓘ

Genetics 65
- BRCA gene mutations in cancer 62
- Genomic variations and chromosomal abnormalities 7
Reproductive Medicine 7
- Ovarian cancer diagnosis and treatment 6

Co-authors: Susan M. Domchek (39 shared papers)Timothy R. Rebbeck (6 shared papers)Katherine L. Nathanson (20 shared papers)Judy E. Garber (12 shared papers)Barbara L. Weber (4 shared papers)Katrina Armstrong (7 shared papers)Chanita Hughes Halbert (11 shared papers)Barbara Weber (5 shared papers)
Journals: Journal of Clinical Oncology (15 papers)Genetics in Medicine (4 papers)Familial Cancer (3 papers)Breast Cancer Research and Treatment (3 papers)Psycho-Oncology (2 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

Jill E. Stopfer

65 papers receiving 2.6k citations

Hit Papers

align trajectories log scale

BRCA1Mutations in Women Attending Clinics That Evaluate the Risk of Breast Cancer 1997 · 506 citations

Peers

Countries citing papers authored by Jill E. Stopfer

Since Specialization

Citations

This map shows the geographic impact of Jill E. Stopfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill E. Stopfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill E. Stopfer more than expected).

Fields of papers citing papers by Jill E. Stopfer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill E. Stopfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill E. Stopfer. The network helps show where Jill E. Stopfer may publish in the future.

Co-authors

The 25 scholars most cited alongside Jill E. Stopfer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jill E. Stopfer Line = papers co-authored together Jill E. Stopfer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	BRCA1Mutations in Women Attending Clinics That Evaluate the Risk of Breast Cancer New England Journal of Medicine ·Fergus J. Couch, Michelle L. DeShano, M. Anne Blackwood, (unknown), Jill E. Stopfer, Lisa Campeau, Arupa Ganguly, Timothy R. Rebbeck, Barbara L. Weber, Lisa Jablon, Melody Cobleigh, Kent Hoskins, Judy E. Garber Hit paper breakdown →	1997	506
2	Application of Breast Cancer Risk Prediction Models in Clinical Practice Journal of Clinical Oncology ·Susan M. Domchek, Andrea Eisen, (unknown), Jill E. Stopfer, Anne M. Blackwood, Barbara Weber	2003	143
3	Factors Determining Dissemination of Results and Uptake of Genetic Testing in Families with Known BRCA1/2 Mutations Genetic Testing ·Esmé Finlay, Jill E. Stopfer, E. Burlingame, Katherine G. Evans, Katherine L. Nathanson, Barbara Weber, Katrina Armstrong, Timothy R. Rebbeck, Susan M. Domchek	2008	128
4	Anticipated Versus Actual Emotional Reactions to Disclosure of Results of Genetic Tests for Cancer Susceptibility: Findings From p53 and BRCA1 Testing Programs Journal of Clinical Oncology ·Michel Dorval, Andrea Farkas Patenaude, Katherine A. Schneider, Stephanie Kieffer, L. Digianni, Kathy J. Kalkbrenner, Jonas I. Bromberg, Laura A. Basili, (unknown), Jill E. Stopfer, Barbara L. Weber, Judy E. Garber	2000	116
5	Factors associated with decisions about clinical BRCA1/2 testing. PubMed ·Katrina Armstrong, (unknown), Jill E. Stopfer, Genevieve FitzGerald, J. C. Coyne, B Weber	2000	109
6	Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast cancer Genetics in Medicine ·Kara N. Maxwell, Bradley Wubbenhorst, Kurt D’Andrea, Bradley Garman, Jessica M. Long, Jacquelyn Powers, Katherine Rathbun, Jill E. Stopfer, Jiajun Zhu, Angela R. Bradbury, Michael S. Simon, Angela DeMichele, Susan M. Domchek, Katherine L. Nathanson	2014	106
7	Biallelic Deleterious BRCA1 Mutations in a Woman with Early-Onset Ovarian Cancer Cancer Discovery ·Susan M. Domchek, Jiang-bo Tang, Jill E. Stopfer, Dana R. Lilli, Nancy Hamel, Marc Tischkowitz, Álvaro N.A. Monteiro, Troy E. Messick, Jacquelyn M. Powers, Alexandria Yonker, Fergus J. Couch, David E. Goldgar, H. Rosemarie Davidson, Katherine L. Nathanson, William D. Foulkes, Roger A. Greenberg	2012	101
8	The Relative Contribution of Point Mutations and Genomic Rearrangements in BRCA1 and BRCA2 in High-Risk Breast Cancer Families Cancer Research ·Maurizia Dalla Palma, Susan M. Domchek, Jill E. Stopfer, Julie Erlichman, Jill D. Siegfried, Jessica Tigges-Cardwell, Bernard A. Mason, Timothy R. Rebbeck, Katherine L. Nathanson	2008	82
9	Utilizing Remote Real-Time Videoconferencing to Expand Access to Cancer Genetic Services in Community Practices: A Multicenter Feasibility Study Journal of Medical Internet Research ·Angela R. Bradbury, Linda Patrick‐Miller, Diana Harris, Evelyn Stevens, Brian L. Egleston, Kyle Smith, Rebecca Mueller, Amanda Brandt, Jill E. Stopfer, Shea Rauch, Andrea Forman, Rebecca Kim, Dominique Fetzer, Linda Fleisher, Mary B. Daly, Susan M. Domchek	2016	75
10	Low rates of acceptance of BRCA1 and BRCA2 test results among African American women at increased risk for hereditary breast-ovarian cancer Genetics in Medicine ·Chanita Hughes Halbert, Lisa Kessler, Jill E. Stopfer, Susan M. Domchek, E. Paul Wileyto	2006	61
11	Long-Term Reactions to Genetic Testing forBRCA1andBRCA2Mutations: Does Time Heal Women's Concerns? Journal of Clinical Oncology ·Chanita Hughes Halbert, Jill E. Stopfer, Jasmine A. McDonald, Benita Weathers, Aliya Collier, Andrea B. Troxel, Susan M. Domchek	2011	59
12	Role of the genetic counselor in familial cancer. PubMed ·June A. Peters, Jill E. Stopfer	1996	51
13	Satisfaction with genetic counseling for BRCA1 and BRCA2 mutations among African American women Patient Education and Counseling ·Sarah Charles, Lisa Kessler, Jill E. Stopfer, Susan M. Domchek, Chanita Hughes Halbert	2006	48
14	Exercise lowers estrogen and progesterone levels in premenopausal women at high risk of breast cancer Journal of Applied Physiology ·D. A. Kossman, Nancy I. Williams, Susan M. Domchek, Mindy S. Kurzer, Jill E. Stopfer, Kathryn H. Schmitz	2011	48
15	Patient feedback and early outcome data with a novel tiered-binned model for multiplex breast cancer susceptibility testing Genetics in Medicine ·Angela R. Bradbury, Linda Patrick‐Miller, Brian L. Egleston, Laura DiGiovanni, Jamie Brower, Diana Harris, Evelyn Stevens, Kara N. Maxwell, Abha Kulkarni, T.A. Vela Chavez, Amanda Brandt, Jessica M. Long, Jacquelyn Powers, Jill E. Stopfer, Katherine L. Nathanson, Susan M. Domchek	2015	46
16	Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy Familial Cancer ·Justine V. Cohen, Laura Chiel, Leigh Boghossian, Marisa Jones, Jill E. Stopfer, Jacquelyn Powers, Timothy R. Rebbeck, Katherine L. Nathanson, Susan M. Domchek	2011	44
17	Recruiting African American Women to Participate in Hereditary Breast Cancer Research Journal of Clinical Oncology ·Chanita Hughes Halbert, Kiyona Brewster, Aliya Collier, C.H. Smith, Lisa Kessler, Benita Weathers, Jill E. Stopfer, Susan M. Domchek, E. Paul Wileyto	2005	43
18	Knowledge, Attitudes, and Utilization of BRCA1/2 Testing among Women with Early-Onset Breast Cancer Genetic Testing ·Nikki Peters, Susan M. Domchek, Abigail Rose, Rachael L. Polis, Jill E. Stopfer, Katrina Armstrong	2005	41
19	Early use of clinical BRCA1/2 testing: Associations with race and breast cancer risk American Journal of Medical Genetics Part A ·Katrina Armstrong, Barbara Weber, Jill E. Stopfer, (unknown), Mary Putt, James Coyne, J. Sanford Schwartz	2002	40
20	Risk of metachronous breast cancer after BRCA mutation–associated ovarian cancer Cancer ·Susan M. Domchek, Komal Jhaveri, Sujata Patil, Jill E. Stopfer, Clifford A. Hudis, Jacquelyn Powers, Zsofia K. Stadler, Laura H. Goldstein, Noah D. Kauff, Mustafa Khasraw, Kenneth Offit, Katherine L. Nathanson, Mark E. Robson	2012	40

About Jill E. Stopfer

Jill E. Stopfer is a scholar working on Genetics, Reproductive Medicine, Pathology and Forensic Medicine, Oncology and Public Health, Environmental and Occupational Health, having authored 69 papers that have together received 2.6k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (62 papers), Ethics in Clinical Research (14 papers), Genetic factors in colorectal cancer (11 papers), Prenatal Screening and Diagnostics (7 papers), Cancer Genomics and Diagnostics (7 papers), DNA Repair Mechanisms (7 papers), Genomic variations and chromosomal abnormalities (7 papers) and Ovarian cancer diagnosis and treatment (6 papers). The work is most often cited by research in Genetics (2.1k citations), Cancer Research (494 citations), Reproductive Medicine (229 citations), Pathology and Forensic Medicine (467 citations) and Oncology (598 citations). Jill E. Stopfer has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Susan M. Domchek, Timothy R. Rebbeck, Katherine L. Nathanson, Judy E. Garber, Barbara L. Weber, Katrina Armstrong, Chanita Hughes Halbert, Barbara Weber, Fergus J. Couch and Lisa Kessler. Their work appears in journals such as Journal of Clinical Oncology, Genetics in Medicine, Familial Cancer, Breast Cancer Research and Treatment and Psycho-Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact